ACN: ASH Research Collaborative Data Hub Launches COVID-19 Registry for Hematology
ASH Clinical News recently covered the launch of the ASH RC Data Hub COVID-19 Registry.
Entries by admin
ASCO Post: William A. Wood, MD, MPH, on the New ASH Research Collaborative Data Hub COVID-19 Registry for Hematologic Malignancy
The Data Hub’s Oversight Group Chair, Dr. William Wood, was recently interviewed by the ASCO Post about the ASH RC Data Hub COVID-19 Registry for Hematologic Malignancy.
PCOR-2-FHIR Data Transfer Successfully Performed
The Center for Health Information Partnerships (CHIP), the ASH Research Collaborative (ASH RC), and Prometheus Research have collaborated to develop a “communicator” between two nationwide health data standards.
Healio: Data Registry to Guide Care for Patients with COVID-19, Blood Cancers
The ASH Research Collaborative’s Data Hub COVID-19 Registry for Hematologic Malignancy was recently covered in Healio.
ASH Research Collaborative’s Data Hub Creates International Data Registry to Help Inform Care for People with Blood Cancers and COVID-19
A global registry for COVID-19 cases.
The Hematologist: Update on the ASH Research Collaborative Data Hub
Dr. William Wood provided an update on the ASH Research Collaborative Data Hub in a recent issue of the Hematologist.
First Industry Datasets Submitted to ASH Research Collaborative Data Hub
The ASH Research Collaborative (ASH RC) has collaborated with two industry leaders, Novartis Pharmaceuticals Corporation (Novartis) and Amgen, to include de-identified patient data from three separate studies of nearly 500 patients living with Sickle Cell Disease (SCD) and more than 1,000 patients with multiple myeloma as part of an unprecedented data sharing initiative.
Inside a Patient Centered Approach to Treating Sickle Cell Disease
The ASH Research Collaborative’s Sickle Cell Disease (SCD) Clinical Trials Network (CTN) patient-centered approach was recently featured in Media Planet’s Clinical Trials issue.
The Hematologist: The Sickle Cell Clinical Trials Network: One Year In
The ASH Research Collaborative Leadership provides a progress report on the development of the Sickle Cell Disease Clinical Trials Network.
HemOncToday: ASH launches sickle cell disease clinical trials network to accelerate therapy development
The Sickle Cell Disease Clinical Trials Network’s ambitious goal of accelerating development of novel therapies for patients with sickle cell disease was covered by HemOnc Today.
ASH RESEARCH COLLABORATIVE
The ASH Research Collaborative (ASH RC) is a non-profit organization established by the American Society of Hematology (ASH) in 2017 to improve the lives of people affected by blood diseases by fostering collaborative partnerships to accelerate progress in hematology. Learn more about ASH RC